Elan

115 results

Revenue, they are likely to look askance at 2009 losses they have never heard of suddenly appearing on a tax return.

I made some losses on both the Elan and Waterford Crystal price collapses some years ago. Is it too late to offset these against gains made during the(...)

Adapt Pharma developed a non-injectable form of Naloxone,  which resulted in a $735 million payday for its investors,  including serial pharmaceutical entrepreneur Séamus Mulligan

You’d never say that a $735 million payday was not a landmark occasion but the sale of Adapt Pharma – the maker of the opioid rescue drug Narcan that (...)

The Sharp Building at Hogan Place, Dublin 2

Perrigo, the leading global healthcare supplier, is to rent an impressive new €20 million headquarters office building developed by the McGarrell Rei(...)

Aisling Quirke in Johannesburg: an active member of Business Ireland Southern Africa

Aisling Quirke was bitten by the travel bug after spending time in Konstanz, Germany, on a government scholarship while still at secondary school. Sh(...)

Tony O’Brien, director-general of the HSE, arriving  for a meeting of the Joint Committee on Health, on issues  surrounding the CervicalCheck Programme, at Leinster House on Wednesday. Photograph: Dara Mac Dónaill

Taoiseach Leo Varadkar has defended his relationship with the chairman of the Mater Hospital, who chairs the board of a US firm that HSE director-gene(...)

Alkermes reckons more than eight million people in the US alone suffer from a major depressive disorder. File photograph: Getty Images

Shares in Irish biopharma group Alkermes jumped sharply after the United States Food and Drug Administration (FDA) agreed to reconsider a depression d(...)

Kelly Martin has taken over as interim chief executive of US group Novan. He will juggle his time with his existing role as CEO of Malin Corporation. Photograph: Joe St Leger

Kelly Martin, the chief executive of Dublin-headquartered life sciences group Malin Corporation, has been appointed as interim chief executive of derm(...)

Richard Pops, Alkermes chief executive, received a lower salary last year. Photograph: Dara Mac Dónaill / The Irish Times

Executives at Irish-headquartered biopharma group Alkermes received lower overall remuneration last year. The group, which is domiciled in Ireland fo(...)

The falure of its Alzheimer medicine - known as Solanezumab, or Sola -  wiped $10 billion off Lilly’s market capitalisation in a single day.

The suspense inside the offices of Eli Lilly this autumn was all but unbearable. After working on a drug to fight Alzheimer’s disease for 15 years, em(...)

Tysabri, the multiple sclerosis drug developed by Elan, may be sold again as Perrigo examines options.

Consumer health and generics group Perrigo is reviewing strategic options for royalty rights from sales of its multiple sclerosis drug Tysabri after r(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »